3

OWNERSHIP DOCUMENT

Company: Xenon Pharmaceuticals Inc.
Filed: April 4, 2016
Period of Report: April 4, 2016
Accession Number: 0001171843-16-009005

View Document ↗ View on SEC.gov ↗